Andrea Sitlinger | Scholars@Duke

Andrea Sitlinger
Medical Instructor in the Department of Medicine

Current Research Interests

My research focuses specifically on improving clinical outcomes for lymphoma patients with interventions in exercise, survivorship, and financial toxicity. I also participate in a number of treatment related clinical trials to help patients access the latest available treatments and continue to improve our treatment options for these patients.

I thoroughly enjoy each opportunity for patient care, and my patients are truly the driver for my research questions and interests. Overall, I hope to 1) provide each patient with a personalized experience that optimizes his or her own care and 2) advance the field of survivorship and chronic cancer management to inform the overall care of these patients and ultimately improve their outcomes.

Current Appointments & Affiliations

Medical Instructor in the Department of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2019
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2019

Contact Information

andrea.sitlinger@duke.edu

Background
Education, Training, & Certifications
- Senior Fellow, Hematology / Oncology, Duke Universitymedical Center, Duke University 2016 - 2019
- Internal Medicine Residency, Duke University Medical Center, Duke University 2013 - 2016
- M.D., University of Cincinnati, College of Medicine 2013
- B.S., Miami University, Hamilton 2006
Medical Licensure
- 2019-01277. North Carolina. 2019
Expertise
Subject Headings
Research
Selected Grants
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Gordon, Max J., Andy Kaempf, Andrea Sitlinger, Geoffrey Shouse, Matthew Mei, Danielle M. Brander, Tareq Salous, et al. “The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27, no. 17 (September 2021): 4814–24. https://doi.org/10.1158/1078-0432.ccr-20-3993.
    Full Text
  - Sitlinger, Andrea, Michael A. Deal, Erwin Garcia, Dana K. Thompson, Tiffany Stewart, Grace A. MacDonald, Nicolas Devos, et al. “Physiological Fitness and the Pathophysiology of Chronic Lymphocytic Leukemia (CLL).” Cells 10, no. 5 (May 11, 2021). https://doi.org/10.3390/cells10051165.
    Full Text
  - Mato, Anthony R., Nilanjan Ghosh, Stephen J. Schuster, Nicole Lamanna, John M. Pagel, Ian W. Flinn, Jacqueline C. Barrientos, et al. “Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy.” Blood 137, no. 20 (May 2021): 2817–26. https://doi.org/10.1182/blood.2020007376.
    Full Text
  - Eyre, Toby A., Nicole Lamanna, Lindsey E. Roeker, Chaitra S. Ujjani, Brian T. Hill, Paul M. Barr, Erick Lansigan, et al. “Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia.” Haematologica 106, no. 1 (January 1, 2021): 284–87. https://doi.org/10.3324/haematol.2019.241539.
    Full Text Link to Item
  - Roeker, Lindsey E., Peter Dreger, Jennifer R. Brown, Oscar B. Lahoud, Toby A. Eyre, Danielle M. Brander, Alan Skarbnik, et al. “Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents.” Blood Adv 4, no. 16 (August 25, 2020): 3977–89. https://doi.org/10.1182/bloodadvances.2020001956.
    Full Text Link to Item
  - Mato, Anthony R., Lindsey E. Roeker, Ryan Jacobs, Brian T. Hill, Nicole Lamanna, Danielle Brander, Mazyar Shadman, et al. “Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.” Clin Cancer Res 26, no. 14 (July 15, 2020): 3589–96. https://doi.org/10.1158/1078-0432.CCR-19-3815.
    Full Text Link to Item
  - Sitlinger, Andrea, Danielle M. Brander, and David B. Bartlett. “Impact of exercise on the immune system and outcomes in hematologic malignancies.” Blood Adv 4, no. 8 (April 28, 2020): 1801–11. https://doi.org/10.1182/bloodadvances.2019001317.
    Full Text Link to Item
  - Roeker, Lindsey E., Christopher P. Fox, Toby A. Eyre, Danielle M. Brander, John N. Allan, Stephen J. Schuster, Chadi Nabhan, et al. “Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice.” Clin Cancer Res 25, no. 14 (July 15, 2019): 4264–70. https://doi.org/10.1158/1078-0432.CCR-19-0361.
    Full Text Link to Item
  - Mato, Anthony R., Lindsey E. Roeker, Toby A. Eyre, Chadi Nabhan, Nicole Lamanna, Brian T. Hill, Danielle M. Brander, et al. “A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.” Blood Adv 3, no. 10 (May 28, 2019): 1568–73. https://doi.org/10.1182/bloodadvances.2019000180.
    Full Text Link to Item
  - Ortel, Thomas L., Katie Arnold, Michele Beckman, Audrey Brown, Nimia Reyes, Ibrahim Saber, Ryan Schulteis, Bhavana Pendurthi Singh, Andrea Sitlinger, and Elizabeth H. Thames. “Design and Implementation of a Comprehensive Surveillance System for Venous Thromboembolism in a Defined Region Using Electronic and Manual Approaches.” Appl Clin Inform 10, no. 3 (May 2019): 552–62. https://doi.org/10.1055/s-0039-1693711.
    Full Text Link to Item
  - Sitlinger, Andrea, Rebecca A. Shelby, Alyssa N. Van Denburg, Heidi White, Sarah N. Edmond, Paul K. Marcom, Hayden B. Bosworth, Francis J. Keefe, and Gretchen G. Kimmick. “Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer.” J Geriatr Oncol 10, no. 2 (March 2019): 317–21. https://doi.org/10.1016/j.jgo.2018.11.008.
    Full Text Link to Item
  - Sitlinger, Andrea, and Syed Yousuf Zafar. “Health-Related Quality of Life: The Impact on Morbidity and Mortality.” Surg Oncol Clin N Am 27, no. 4 (October 2018): 675–84. https://doi.org/10.1016/j.soc.2018.05.008.
    Full Text Link to Item
  - Mato, Anthony R., Meghan Thompson, John N. Allan, Danielle M. Brander, John M. Pagel, Chaitra S. Ujjani, Brian T. Hill, et al. “Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.” Haematologica 103, no. 9 (September 2018): 1511–17. https://doi.org/10.3324/haematol.2018.193615.
    Full Text Link to Item
  - Sitlinger, Andrea Phillips, and S Yousuf Zafar. “With Colorectal Cancer Treatment, Physical Toxicity Is Not the Only Concern.” Dis Colon Rectum 61, no. 1 (January 2018): 4–5. https://doi.org/10.1097/DCR.0000000000000922.
    Full Text Link to Item
  - Sitlinger, A. P., C. J. Lindsell, A. H. Ruffner, D. B. Wayne, K. W. Hart, A. T. Trott, C. J. Fichtenbaum, and M. S. Lyons. “Preliminary program evaluation of emergency department HIV prevention counseling.” Annals of Emergency Medicine 58, no. 1 SUPPL. (January 1, 2011). https://doi.org/10.1016/j.annemergmed.2011.03.036.
    Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Medical Licensure

Subject Headings

Selected Grants

Selected Publications

Academic Articles